CD8A and metastatic neoplasm: FABP7+ macrophages transferred TG-enriched exosomes to CD8+ T cells, driving PD-1 upregulation, this interaction suggests therapeutic synergy between FABP7 inhibition and anti-PD1 immunotherapy in metastatic disease.